Invention Application
- Patent Title: APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES
-
Application No.: US12951344Application Date: 2010-11-22
-
Publication No.: US20110124628A1Publication Date: 2011-05-26
- Inventor: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert Mantei , Todd M. Hansen
- Applicant: Milan Bruncko , Hong Ding , George A. Doherty , Steven W. Elmore , Lisa A. Hasvold , Laura Hexamer , Aaron R. Kunzer , Xiaohong Song , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Michael D. Wendt , Robert Mantei , Todd M. Hansen
- Applicant Address: US IL Abbott Park
- Assignee: ABBOTT LABORATORIES
- Current Assignee: ABBOTT LABORATORIES
- Current Assignee Address: US IL Abbott Park
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D471/04 ; C07D401/14 ; C07D403/14 ; C07D405/14 ; A61K31/5377 ; A61K31/517 ; A61K31/541 ; A61P35/00 ; A61P35/02
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US08580794B2 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Public/Granted day:2013-11-12
Information query
IPC分类:
